Back to top
more

MEDNAX, Inc. (MD)

(Delayed Data from NYSE)

$29.24 USD

29.24
451,297

+0.50 (0.50%)

Updated Jul 26, 2021 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.57%
2Buy19.14%
3Hold10.74%
4Sell6.46%
5Strong Sell3.16%
S&P50011.27%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 13% (34 out of 252)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Company Summary

Incorporated in Florida in 2007, MEDNAX, Inc is the successor of Pediatrix Medical Group, Inc., which was founded in Florida in 1979. The company provides newborn, maternal-fetal, radiology, pediatric cardiology and other pediatric subspecialties physician services in the United States and Puerto Rico. It also offers neonatal care services such as, clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners and other pediatric clinicians, etc.

The company exited 2020 with 2300 affiliated physicians including 1,320 physicians, who deliver neonatal clinical care, primarily within hospital-based ...

General Information

MEDNAX, Inc.

1301 CONCORD TERRACE

SUNRISE, FL 33323

Phone: 954-384-0175

Fax: 954-838-9961

Web: http://www.mednax.com

Email: charles_lynch@mednax.com

Industry Medical - Hospital
Sector Medical
Fiscal Year End December
Last Reported Quarter 6/30/2021
Next EPS Date 8/6/2021

EPS Information

Current Quarter EPS Consensus Estimate 0.33
Current Year EPS Consensus Estimate 1.36
Estimated Long-Term EPS Growth Rate 16.10
Next EPS Report Date 8/6/2021

Price and Volume Information

Zacks Rank Premium
Yesterday's Close 28.74
52 Week High 34.19
52 Week Low 12.47
Beta 2.15
20 Day Moving Average 433,422.94
Target Price Consensus 26.29

MD

% Price Change
4 Week -4.16
12 Week 10.47
YTD 19.15
% Price Change Relative to S&P 500
4 Week -7.02
12 Week 4.73
YTD -0.29
Share Information
Shares Outstanding (millions) 86.28
Market Capitalization (millions) 2,522.78
Short Ratio NA
Last Split Date 12/20/2013
Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

Fundamental Ratios

P/E
P/E (F1) 21.18
Trailing 12 Months 24.36
PEG Ratio 1.31
EPS Growth
vs. Previous Year -20.00%
vs. Previous Quarter -9.09%
   
Sales Growth
vs. Previous Year -47.19%
vs. Previous Quarter 7.23%
   
Price Ratios
Price/Book 3.23
Price/Cash Flow 24.90
Price / Sales 1.35
ROE
6/30/21 NA
3/31/21 10.90
12/31/20 9.17
ROA
6/30/21 NA
3/31/21 2.71
12/31/20 2.45
Current Ratio
6/30/21 NA
3/31/21 2.04
12/31/20 3.49
Quick Ratio
6/30/21 NA
3/31/21 2.04
12/31/20 3.49
Operating Margin
6/30/21 NA
3/31/21 4.68
12/31/20 3.97
Net Margin
6/30/21 NA
3/31/21 -41.46
12/31/20 -35.68
Pre-Tax Margin
6/30/21 NA
3/31/21 1.36
12/31/20 0.41
Book Value
6/30/21 NA
3/31/21 8.90
12/31/20 8.74
Inventory Turnover
6/30/21 NA
3/31/21 NA
12/31/20 NA
Debt-to-Equity
6/30/21 NA
3/31/21 1.30
12/31/20 2.33
Debt to Capital
6/30/21 NA
3/31/21 56.52
12/31/20 69.97